| __timestamp | MiMedx Group, Inc. | Pharming Group N.V. |
|---|---|---|
| Wednesday, January 1, 2014 | 12665000 | 4167274 |
| Thursday, January 1, 2015 | 20202000 | 5247851 |
| Friday, January 1, 2016 | 32407000 | 4925118 |
| Sunday, January 1, 2017 | 35219000 | 14930297 |
| Monday, January 1, 2018 | 36386000 | 25371768 |
| Tuesday, January 1, 2019 | 43081000 | 23921274 |
| Wednesday, January 1, 2020 | 39330000 | 25338236 |
| Friday, January 1, 2021 | 43283000 | 20182966 |
| Saturday, January 1, 2022 | 48316000 | 17562000 |
| Sunday, January 1, 2023 | 54634000 | 25212000 |
Unveiling the hidden dimensions of data
In the ever-evolving biotech industry, understanding cost structures is crucial for investors and stakeholders. This analysis focuses on the cost of revenue trends for Pharming Group N.V. and MiMedx Group, Inc. from 2014 to 2023. Over this period, MiMedx Group, Inc. has seen a steady increase in its cost of revenue, peaking at approximately 54.6 million in 2023, a remarkable 330% increase from 2014. In contrast, Pharming Group N.V. experienced a more volatile trajectory, with costs rising by over 500% from 2014 to 2018, before stabilizing around 25 million in recent years. These trends highlight the differing financial strategies and market challenges faced by these companies. Investors should consider these cost dynamics when evaluating potential growth and profitability in the biotech sector.
Cost of Revenue Trends: Novo Nordisk A/S vs MiMedx Group, Inc.
Analyzing Cost of Revenue: Vertex Pharmaceuticals Incorporated and Pharming Group N.V.
United Therapeutics Corporation vs Pharming Group N.V.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Intra-Cellular Therapies, Inc. vs Pharming Group N.V.
Comparing Cost of Revenue Efficiency: Pharming Group N.V. vs Agios Pharmaceuticals, Inc.
Cost Insights: Breaking Down Pharming Group N.V. and Dyne Therapeutics, Inc.'s Expenses
Pharming Group N.V. vs Travere Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Pharming Group N.V. vs BioCryst Pharmaceuticals, Inc.
Cost Insights: Breaking Down Ligand Pharmaceuticals Incorporated and MiMedx Group, Inc.'s Expenses
Cost of Revenue Comparison: Wave Life Sciences Ltd. vs MiMedx Group, Inc.
Comparing Cost of Revenue Efficiency: Celldex Therapeutics, Inc. vs MiMedx Group, Inc.